ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Essilor Luxottica (PK)

Essilor Luxottica (PK) (ESLOF)

267.665
9.59
(3.72%)
Closed January 22 3:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
267.665
Bid
249.57
Ask
276.11
Volume
429
260.17 Day's Range 272.00
189.50 52 Week Range 263.00
Market Cap
Previous Close
258.0749
Open
267.14
Last Trade
7
@
267.665
Last Trade Time
Financial Volume
US$ 113,643
VWAP
264.9021
Average Volume (3m)
1,272
Shares Outstanding
445,231,933
Dividend Yield
2.58%
PE Ratio
52.06
Earnings Per Share (EPS)
5.14
Revenue
25.4B
Net Profit
2.29B

About Essilor Luxottica (PK)

Essilor International is engaged in the manufacture, purchase, sale, and trade in any and all eyewear and optical products. In particular, Co. manufactures, purchases and sells spectacle frames, sunglasses, protective glasses and other protective equipment, eyeglass and contact lenses and any and al... Essilor International is engaged in the manufacture, purchase, sale, and trade in any and all eyewear and optical products. In particular, Co. manufactures, purchases and sells spectacle frames, sunglasses, protective glasses and other protective equipment, eyeglass and contact lenses and any and all instruments and materials for use by members of the optical ophthalmics industry. Co.'s ophthalmic lens industry is organized around four separate businesses: raw materials production, series production of lenses, prescription lenses and distribution (through opticians, optometrists and optical products retailers). Show more

Sector
Ophthalmic Goods
Industry
Ophthalmic Goods
Headquarters
Charenton-le-pont, Val-de-marne, Fra
Founded
1971
Essilor Luxottica (PK) is listed in the Ophthalmic Goods sector of the OTCMarkets with ticker ESLOF. The last closing price for Essilor Luxottica (PK) was US$258.07. Over the last year, Essilor Luxottica (PK) shares have traded in a share price range of US$ 189.50 to US$ 263.00.

Essilor Luxottica (PK) currently has 445,231,933 shares outstanding. The market capitalization of Essilor Luxottica (PK) is US$114.90 billion. Essilor Luxottica (PK) has a price to earnings ratio (PE ratio) of 52.06.

ESLOF Latest News

Paul du Saillant and Laurent Vacherot Appointed Chief Operating Officers

Paul du Saillant and Laurent Vacherot Appointed Chief Operating Officers PR Newswire CHARENTON-LE-PONT, France, November 29, 2010 CHARENTON-LE-PONT, France, November 29, 2010 /PRNewswire/ -- To...

Essilor - Third-Quarter 2010 Report

Essilor - Third-Quarter 2010 Report - Nine-Month Revenue up 17.6% - Strong Sales In Emerging Markets and the Equipment division PR Newswire CHARENTON-LE-PONT, France, October 22, 2010...

Essilor to Acquire 50% of Shamir Optical

Essilor to Acquire 50% of Shamir Optical PR Newswire KIBBUTZ SHAMIR, Israel and CHARENTON-LE-PONT, France, October 15, 2010 KIBBUTZ SHAMIR, Israel and CHARENTON-LE-PONT, France, October 15, 2010...

Essilor - First-Half 2010 Results

Essilor - First-Half 2010 Results PR Newswire CHARENTON-LE-PONT, France, August 27, 2010 CHARENTON-LE-PONT, France, August 27, 2010 /PRNewswire/ -- - A Very Good First Half - Sharp Increase...

Essilor Cancels Four Million Shares

Essilor Cancels Four Million Shares PR Newswire CHARENTON-LE-PONT, France, July 13, 2010 CHARENTON-LE-PONT, France, July 13, 2010 /PRNewswire/ -- On June 28, 2010, Essilor cancelled 4,000,000...

Essilor to Appeal Against the BKA's Decision on Anti-Cartel Rules

Essilor to Appeal Against the BKA's Decision on Anti-Cartel Rules PR Newswire CHARENTON-LE-PONT, France, June 10, 2010 CHARENTON-LE-PONT, France, June 10, 2010 /PRNewswire/ -- Essilor was...

Essilor Sells its Stake in Sperian Protection

Essilor Sells its Stake in Sperian Protection PR Newswire CHARENTON-LE-PONT, France, May 19, 2010 CHARENTON-LE-PONT, France, May 19, 2010 /PRNewswire/ -- Sperian Protection's Board of Directors...

Essilor: 2010 Combined Ordinary and Extraordinary Annual Meeting

Essilor: 2010 Combined Ordinary and Extraordinary Annual Meeting PR Newswire PARIS, May 11, 2010 PARIS, May 11, 2010 /PRNewswire/ -- The Combined Ordinary and Extraordinary Annual Meeting of...

Essilor - 2010 First Quarter Report

Essilor - 2010 First Quarter Report - A Solid First Quarter, With Revenue Up 7.8% PR Newswire CHARENTON-LE-PONT, France, April 23, 2010 CHARENTON-LE-PONT, France, April 23, 2010 /PRNewswire/...

Essilor Acquires Signet Armorlite, Exclusive Manufacturer of KODAK Lenses

Essilor Acquires Signet Armorlite, Exclusive Manufacturer of KODAK Lenses PR Newswire CHARENTON-LE-PONT, France, April 2, 2010 CHARENTON-LE-PONT, France, April 2, 2010 /PRNewswire/ -- Following...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
128.78512.0499832552238.88263238.88463249.36629751CS
430.66512.9388185654237263232632241.99485076CS
1235.01515.0505050505232.652632281272242.68350544CS
2652.66524.4953488372215263200.74882238.35328548CS
5271.41536.3898089172196.25263189.5889226.50303089CS
15672.66537.2641025641195263131.481653182.27392517CS
260112.66572.6870967742155263101.51784170.86676368CS

ESLOF - Frequently Asked Questions (FAQ)

What is the current Essilor Luxottica (PK) share price?
The current share price of Essilor Luxottica (PK) is US$ 267.665
How many Essilor Luxottica (PK) shares are in issue?
Essilor Luxottica (PK) has 445,231,933 shares in issue
What is the market cap of Essilor Luxottica (PK)?
The market capitalisation of Essilor Luxottica (PK) is USD 114.9B
What is the 1 year trading range for Essilor Luxottica (PK) share price?
Essilor Luxottica (PK) has traded in the range of US$ 189.50 to US$ 263.00 during the past year
What is the PE ratio of Essilor Luxottica (PK)?
The price to earnings ratio of Essilor Luxottica (PK) is 52.06
What is the cash to sales ratio of Essilor Luxottica (PK)?
The cash to sales ratio of Essilor Luxottica (PK) is 4.69
What is the reporting currency for Essilor Luxottica (PK)?
Essilor Luxottica (PK) reports financial results in EUR
What is the latest annual turnover for Essilor Luxottica (PK)?
The latest annual turnover of Essilor Luxottica (PK) is EUR 25.4B
What is the latest annual profit for Essilor Luxottica (PK)?
The latest annual profit of Essilor Luxottica (PK) is EUR 2.29B
What is the registered address of Essilor Luxottica (PK)?
The registered address for Essilor Luxottica (PK) is 147 RUE DE PARIS, CHARENTON-LE-PONT, VAL-DE-MARNE, 94220
What is the Essilor Luxottica (PK) website address?
The website address for Essilor Luxottica (PK) is www.essilorluxottica.com
Which industry sector does Essilor Luxottica (PK) operate in?
Essilor Luxottica (PK) operates in the OPHTHALMIC GOODS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RTNBroot9B Holdings Inc (CE)
US$ 0.003003
(300,200.00%)
333
CTRYFCountry Garden Holdings Company Limited (CE)
US$ 0.075
(37,400.00%)
1.69k
CNQQFClean TeQ Water Ltd (PK)
US$ 0.18
(25,614.29%)
425
QBIOQ BioMed Inc (CE)
US$ 0.0002
(19,900.00%)
692
MGTIMGT Capital Investments Inc (CE)
US$ 0.0002
(19,900.00%)
15.63k
JFTHJapan Food Tech Holdings Inc (CE)
US$ 0.000001
(-99.99%)
150
CONNQConns Inc (CE)
US$ 0.000001
(-99.98%)
250
SPECSpectaire Holdings Inc (CE)
US$ 0.000001
(-99.90%)
6.02k
EGOCEnergy One Corporation (CE)
US$ 0.000001
(-99.90%)
21.8k
GRTSQGritstone bio Inc (CE)
US$ 0.000001
(-99.90%)
223.35k
PDGOParadigm Oil and Gas Inc (PK)
US$ 0.0001
(-50.00%)
574.25M
RDARRaadr Inc (PK)
US$ 0.001
(-9.09%)
280.1M
COSGCosmos Group Holdings Inc (PK)
US$ 0.0002
(19,900.00%)
267.1M
HMBLHUMBL Inc (PK)
US$ 0.0008
(-11.11%)
251.13M
ASIIAccredited Solutions Inc (PK)
US$ 0.0005
(0.00%)
187.29M

Discussion

View Full Feed
ThoroughBread ThoroughBread 3 minutes ago
SFIO .0028 sleeper.
SFIO
glens0 glens0 4 minutes ago
CTOR last Aug. 6th the price was $49.00 now $1.32
CTOR
ThoroughBread ThoroughBread 6 minutes ago
SING @ .006 bounce-pop off this level. Daily volume increasing.
boi568 boi568 6 minutes ago
Yes, it's also true that guidelines allow for more discretion than rules. To a point.

If the governing science that applies to two applicants is the same, the FDA decisional criteria should be the same. In this case, if the AD stages in the trials are the same, the endpoints should be
AVXL
Hardazoak Hardazoak 7 minutes ago
Current Aabbg works fine, wallet works fine. New aabb wallet 2.0 with AI and moonpay exchange integrated coming. Stop with the lies gitreal, only you are believing your own lies.
AABB
KPIFF-LDDFF KPIFF-LDDFF 7 minutes ago
KPIFF
wadegarret wadegarret 8 minutes ago
Novice- AI stocks have mostly done their thing

I don't believe Stargate will add all that much to boost valuations further. I mean NVDA already sells for over a 30 something PE going forward, CRDO sells for an 85 PE going forward, CRWD sells for around an 80 PE going forward, PLTR
AES CRDO CRWD
PEACHMAN PEACHMAN 8 minutes ago
The exact opposite of what you say is true.LOLOLOLOL!!!!! I OWN you, kitty. Heart, mind, body and soul!! You fall into traps, you copy verbatim my posts. Have you ever had an independent thought in your life?

https://investorshub.advfn.com/uimage/uploads/2025/1/22/sdlmono_panther.pn
IFUS
pinhigh pinhigh 9 minutes ago
Well done video gimmee! RRX!
BIEL
Orange Cassidy Orange Cassidy 10 minutes ago
The Jared "whisperer" is still here in emoji form on every post. He has not gone anywhere. As it stands the mills are abandoned and this is still a sham. "Whats not to like?"
NBRI
bas2020 bas2020 10 minutes ago
Any shorting after approval will be total manipulation by the corrupt cabal... your bosses. Hopefully, we'll have MTD denial prior with a cease and desist order to go with it... to cut ya all off at the knees. 💥
NWBO
hssbwwmp hssbwwmp 11 minutes ago
Yes, I've seen them cite those factors in their reports as well as being flexible to adapt to them. So, it would seem that if AXXA was still able to grow revenue and reduce debt despite those factors, then the PPS should not have continued this long downtrend, correct? Something still is not comp
AXXA
RichieBoy RichieBoy 11 minutes ago
Minute 28 - Minute 40 is on AI

Keep in mind this is acutely political. So you'll be left wondering about this side of AI and oh that part of AI why aren't they important. They are important of course, but never before to date will you have seen such intense focus on this one facet.
AFFU
boarddork boarddork 13 minutes ago
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 13 minutes ago
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 13 minutes ago
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 15 minutes ago
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 15 minutes ago
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 16 minutes ago
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 18 minutes ago
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 19 minutes ago
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 19 minutes ago
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 20 minutes ago
Whats 305
RNVA

Your Recent History

Delayed Upgrade Clock